These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24989921)

  • 1. [Clinical features of patients with malignant peritoneal mesothelioma initially presenting as a local inflammation].
    Song H; Zheng G; Wei S; Yang Y; Wei X
    Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):312-3. PubMed ID: 24989921
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case of malignant peritoneal mesothelioma diagnosed with laparoscopic biopsy].
    Yagi Y; Maeda T; Yoshimitsu Y; Sakuma H
    Gan To Kagaku Ryoho; 2014 Aug; 41(8):995-7. PubMed ID: 25132032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pemetrexed combined with platinum-based chemotherapy for advanced malignant peritoneal mesothelioma: retrospective analysis of six cases.
    Nakano M; Kusaba H; Makiyama A; Ariyama H; Arita S; Oda H; Esaki T; Takayoshi K; Uchino K; Tamura S; Kumagai H; Iwama E; Shirakawa T; Mitsugi K; Takaishi S; Akashi K; Baba E
    Anticancer Res; 2014 Jan; 34(1):215-20. PubMed ID: 24403465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of malignant peritoneal mesothelioma with the epithelioid histological type, successfully treated with pemetrexed plus cisplatin].
    Kobayashi M; Moriwaki T; Ochi D; Saito R; Kobayashi K; Sugaya A; Akutsu D; Hamano Y; Imanishi M; Yamamoto Y; Yamada T; Nakano N; Sugano M; Hara K; Hyodo I
    Gan To Kagaku Ryoho; 2014 Mar; 41(3):361-4. PubMed ID: 24743284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A difficult to treat case of malignant peritoneal mesothelioma with peritoneal metastasis].
    Ojima T; Takai Y; Yamazaki K; Kamata T; Kanno M
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2463-5. PubMed ID: 24394145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic strategies for well-differentiated papillary mesothelioma of the peritoneum.
    Lee YK; Jun HJ; Nahm JH; Lim TS; Park JS; Ahn JB; Rha SY; Chung HC; Oh HE; Song JS; Yang WI; Kim HS
    Jpn J Clin Oncol; 2013 Oct; 43(10):996-1003. PubMed ID: 23964112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of the frontline platinum-based combination chemotherapy in malignant peritoneal mesothelioma.
    Kim ST; Park JY; Lee J; Park JO; Park YS; Lim HY; Kang WK; Park SH
    Jpn J Clin Oncol; 2010 Nov; 40(11):1031-6. PubMed ID: 20534685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant pleural and peritoneal mesothelioma: incidental diagnosis and excellent treatment results.
    Miliauskas S; Zemaitis M; Pranys D
    J Thorac Oncol; 2009 Mar; 4(3):435-6. PubMed ID: 19247093
    [No Abstract]   [Full Text] [Related]  

  • 9. Malignant peritoneal mesothelioma (MPM) who responded to rechallenge with cisplatin and pemetrexed with current literature review.
    Gilani SN; Gridley R; Searle G; Jegannathen A
    BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23291819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of systemic pemetrexed-based combination chemotherapy versus cytoreductive surgery and hyperthermic intraperitoneal cisplatin and doxorubicin on survival in malignant peritoneal mesothelioma.
    Saxena A; Chua TC
    Lung Cancer; 2009 Nov; 66(2):269-70. PubMed ID: 19733416
    [No Abstract]   [Full Text] [Related]  

  • 11. The efficacy of pemetrexed and bevacizumab intrapleural injection for malignant pleural mesothelioma-mediated malignant pleural effusion.
    Chen D; Li X; Zhao H; Fu Y; Yao F; Hu J; Du N
    Indian J Cancer; 2014 Mar; 51 Suppl 3():e82-5. PubMed ID: 25818740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant peritoneal mesothelioma: contribution and limitation of imaging for its diagnosis.
    Marrannes J; Delvaux S; Verheezen J
    JBR-BTR; 2009; 92(5):248-50. PubMed ID: 19999328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma.
    Krug LM; Wozniak AJ; Kindler HL; Feld R; Koczywas M; Morero JL; Rodriguez CP; Ross HJ; Bauman JE; Orlov SV; Ruckdeschel JC; Mita AC; Fein L; He X; Hall R; Kawabe T; Sharma S
    Lung Cancer; 2014 Sep; 85(3):429-34. PubMed ID: 25047675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic chemotherapy with pemetrexed and cisplatin for malignant peritoneal mesothelioma: a single institution experience.
    Lainakis G; Zagouri F; Kastritis E; Sergentanis TN; Bozas G; Dimopoulos MA; Papadimitriou CA
    Tumori; 2011; 97(1):25-9. PubMed ID: 21528659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciduoid pleural mesothelioma in an adolescent.
    Arango-Tomás E; Algar-Algar FJ; Salvatierra Velázquez A
    Arch Bronconeumol; 2013 May; 49(5):218-9. PubMed ID: 23265622
    [No Abstract]   [Full Text] [Related]  

  • 16. A case report of peritoneal malignant mesothelioma presenting as primary ovarian mass.
    Kapoor R; Kuttikat PG; Vaiphei K; Rai B; Patel FD
    J Cancer Res Ther; 2015; 11(3):654. PubMed ID: 26458642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long progression-free survival by pemetrexed continuation maintenance therapy following cisplatin-based chemotherapy in malignant pleural mesothelioma.
    Takeda T; Itano H; Fukita S; Saitoh M; Takeda S
    Intern Med; 2014; 53(20):2347-51. PubMed ID: 25318801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant peritoneal mesothelioma in a child: chemotherapy with gemcitabine and platinum was effective for the disease unresponsive to other treatments.
    Kobayashi S; Waragai T; Sano H; Mochizuki K; Akaihata M; Ohara Y; Hosoya M; Kikuta A
    Anticancer Drugs; 2014 Oct; 25(9):1102-5. PubMed ID: 25010395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program.
    Jänne PA; Wozniak AJ; Belani CP; Keohan ML; Ross HJ; Polikoff JA; Mintzer DM; Taylor L; Ashland J; Ye Z; Monberg MJ; Obasaju CK
    Clin Lung Cancer; 2005 Jul; 7(1):40-6. PubMed ID: 16098243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study.
    Buikhuisen WA; Burgers JA; Vincent AD; Korse CM; van Klaveren RJ; Schramel FM; Pavlakis N; Nowak AK; Custers FL; Schouwink JH; Gans SJ; Groen HJ; Strankinga WF; Baas P
    Lancet Oncol; 2013 May; 14(6):543-51. PubMed ID: 23583604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.